Public-site scopeInquiry handling

Privacy notice for the
public Genoll website

This notice explains how Geno Logix Labs Private Limited handles information submitted through this website and how public-site inquiry data is governed under the Indian Digital Personal Data Protection (DPDP) Act, 2023.

What this notice covers

This notice applies strictly to raw and processed information submitted through the public Genoll website, including contact form entries, newsletter signups, direct email outreach initiated from this domain, and minimal browser technical keys (essential cookie variables) required to safely serve pages.

Information you provide

When you initiate an email or submit our website forms, we collect the personal name, organizational details, email address, purpose, and message content you voluntarily outline. Confidential, highly regulated, or proprietary clinical material belongs in the secure, isolated, and contractually sealed channels Genoll establishes after initial mutual screening.

How information is used

Information submitted through this site is used to route, classify, review, and formally respond to your incoming inquiry, maintain an active registry of institution interactions, and support legitimate clinical, scientific, and corporate strategic communication.

Sharing and access

Submitted information is reviewed exclusively by authorized Geno Logix Labs Private Limited clinical operations personnel or vetted cloud IT service providers supporting our website processing. Public pages present static company statements; inbox submissions are held in private registries governed by high-level retention checklists.

Retention and handling

We store public-site inquiries for long-term clinical dialogue continuity and statutory corporate recordkeeping under strict data handling security keys, complying fully with South Asian and European retention guidelines.

Governed channels for clinical data

Raw patient biological records, diagnostics assays, NGS datasets, treatment histories, and protected healthcare information (PHI) must never be typed into public web forms. If your clinical trials or biobanks intend to run sample workflows, use our offline secured portals under isolated Business Associate Agreements (BAAs).

Contact & Questions

If you have questions regarding the processing of public-site enquiries, or wish to request direct, isolated channels, contact our Data Protection Officer at:

Note: This notice regulates public web traffic on this domain. Clinical study confidentiality, co-authorship terms, and raw sequence transfers are strictly governed by the formal bilateral Master Service Agreements configured per project site.